E85.1 Neuropathic heredofamilial amyloidosis

Name of the Condition

• Neuropathic heredofamilial amyloidosis
• ICD-10 Code: E85.1

Summary

Neuropathic heredofamilial amyloidosis is a rare genetic disorder characterized by the accumulation of amyloid proteins in various tissues and organs, with a primary focus on nervous system involvement. This buildup disrupts normal function, leading to health issues that can impact the peripheral nerves, autonomic nervous system, and other organ systems.

Causes

The condition is caused by genetic mutations that lead to the production of abnormal amyloidogenic proteins. These mutations result in the misfolding and deposition of amyloid fibers, which accumulate in tissues over time. The specific genetic mutations vary by subtype but typically involve genes associated with amyloid protein production.

Risk Factors

• Family history of heredofamilial amyloidosis or related genetic conditions.
• Inherited genetic mutations associated with amyloid protein production.
• Age (symptoms typically develop in adulthood).

Symptoms

• Nerve pain and numbness (especially in hands and feet).
• Autonomic dysfunction (e.g., dizziness, gastrointestinal issues, urinary problems).
• Muscle weakness or atrophy.
• Sensory disturbances (e.g., tingling, burning sensations).
• Organ involvement (e.g., heart, kidney, or liver symptoms depending on subtype).

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and tissue biopsy. Biopsy samples are stained with Congo red to confirm amyloid deposits. Additional tests may include genetic testing to identify amyloidogenic mutations and imaging studies to assess organ involvement.

Treatment Options

Treatment focuses on managing symptoms and slowing disease progression. Options may include medications to control neuropathic pain, supportive therapies for autonomic dysfunction, and organ-specific treatments for affected systems. In some cases, liver transplantation or other interventions may be considered.

Prognosis and Follow-Up

Prognosis varies depending on the subtype and extent of organ involvement. Regular follow-up is essential to monitor disease progression, manage complications, and adjust treatment plans. Early diagnosis and intervention can improve outcomes.

Complications

• Progressive nerve damage leading to disability.
• Autonomic dysfunction affecting vital functions.
• Organ failure (e.g., heart, kidney, or liver) in advanced cases.
• Reduced quality of life due to chronic symptoms.

Lifestyle & Prevention

• Genetic counseling for affected families to assess risk.
• Symptom management through lifestyle adjustments (e.g., pain relief, mobility support).
• Regular monitoring of organ function to detect complications early.

When to Seek Professional Help

Seek medical attention if you experience persistent neuropathic symptoms (e.g., numbness, pain) or signs of organ dysfunction (e.g., swelling, shortness of breath). Early evaluation is critical for diagnosis and management.

Tips for Medical Coders

Document the presence of neuropathic symptoms and family history to support the E85.1 code. Ensure biopsy confirmation of amyloid deposits and specify organ involvement if applicable. Code accurately to reflect the clinical presentation and genetic basis of the condition.